Zerodol SP is a combination of aceclofenac, serratiopeptidase and paracetamol.
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) with marked anti-inflammatory and analgesic properties. It potently inhibits the synthesis of inflammatory mediators that cause pain, swelling, inflammation, and fever. In osteoarthritis and other such conditions, the loss of articular cartilage in the area causes joint pain, tenderness, stiffness, crepitus, and local inflammation. Aceclofenac has high permeability to penetrate into synovial joints thereby reducing the swelling and inflammation of joints.
Serratiopeptidase is an enzyme and has an anti-inflammatory action, analgesic and antipyretic action.
Paracetamol is an analgesic and antipyretic medication used for mild-to-moderate pain and fever.
Zerodol SP is used in following conditions:
- Bones and joints pain
- Toothache, Ear pain, Headache
- Muscles pain
- Sore throat
- Migraine
- Ear infections
- Swelling
- Menstrual pain
- Fever
- Rheumatoid arthritis
- Ankylosing spondylitis
- Osteoarthritis
Zerodol SP is brand of Ipca, a global pharmaceutical company. Ipca has been partnering healthcare globally in over 120 countries for more than 60 years and in markets as diverse as Africa, Asia, Australia, Europe and the US.
It is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations. The formulations are produced right from the basic stage at manufacturing facilities inspected by the world’s most discerning drug regulatory authorities like US-FDA, UK-MHRA, EDQM-Europe, WHO-Geneva and many more.
Ipca is a therapy leader in India for anti-malarials and has leading brands in 5 therapeutic areas, with 3 of their branded formulations being ranked among the Top-300 Indian brands by ORG-IMS.